2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1891875985 M.D.
Verify on CMS →

MOLLY WALSH, M.D.

Glaucoma Specialist (Ophthalmology) Physician in SOUTHERN PINES, North Carolina. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
759
Medicare Part D claims · 251 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
69%
generic claims · 31% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
89.8555/100
▲ 7 pts above national avg 83.1 · [object Object]
Industry payments
$410.32
5 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MOLLY WALSH, M.D. reported a CMS MIPS final score of 89.8555/100 — above the 83.1 national average — and filed 759 Medicare Part D claims in 2023.

89.8555/100
MIPS score · +7 vs avg
759
Part D claims, 2023
69%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MOLLY WALSH, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

90 Top 42% higher than 58% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MOLLY WALSH, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MOLLY WALSH, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 10/16/2006

NPI 1891875985

Primary specialty

Glaucoma Specialist (Ophthalmology) Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

759 74% vs specialty avg

2023 prescription claims

Specialty avg: 2,962

MIPS final score

89.8555/100 6.755500000000012% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in North Carolina

How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among North Carolina providers

North Carolina providers

Glaucoma Specialist (Ophthalmology) Physician share within North Carolina

1. Glaucoma Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Glaucoma Specialist (Ophthalmology) Physician share within North Carolina

Medicare quality performance — MIPS

MOLLY WALSH, M.D.'s 2023 MIPS final score plotted against the Glaucoma Specialist (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
89.8555/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 89.8555/100 vs national avg 83.1

0%100%National avg83%89.9%
MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 89.8555/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MOLLY WALSH, M.D. appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding M.D. credentials at 2170 MIDLAND RD, SOUTHERN PINES, NC, 28387, with a listed phone of (910) 295-2100. NPI 1891875985 was issued on 10/16/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WALSH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 759 prescription claims written by this provider, covering 251 Medicare beneficiaries and totaling roughly $33K in drug spend, split 31% brand-name and 69% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 89.8555/100 for the 2023 performance year (Quality 100, Cost 66.185), compared with the national average of 83.1.

Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2170 MIDLAND RD
SOUTHERN PINES, NC 28387

Provider Details

NPI 1891875985
Specialty Glaucoma Specialist (Ophthalmology) Physician
Credentials M.D.
Gender Female
NPI Issued 10/16/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

89.8555
Final Score
Avg: 83.1
100
Quality
66.185
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where MOLLY WALSH, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CAROLINA EYE ASSOCIATES INC
SOUTHERN PINES, NC
MICHIANA EYE CENTER LLC
MISHAWAKA, IN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MOLLY WALSH, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$410

Largest payer

Sight Sciences, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

MOLLY WALSH, M.D. — brand share 31.0%
Specialty average (est.)

31% brand-name claims vs 69% generic, on 759 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

759
Total Claims
$33K
Total Drug Cost
251
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
958
Total Day Supply
23,797
Brand vs Generic
31% brand / 69% generic
Brand Drug Cost
$20K
Generic Drug Cost
$13K

Patient Demographics

Average Patient Age
73.0 years
Avg HCC Risk Score
1.28
Gender Split
60% female / 40% male
Age Distribution
<65: 24, 65-74: 126, 75-84: 88, 85+: 13

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MOLLY WALSH, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisolone Acetate
177
Ofloxacin
168
Ketorolac Tromethamine
145
Latanoprost
91
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
38
Timolol Maleate
22
Atropine Sulfate
18
Lumigan
Bimatoprost
18
Brimonidine Tartrate
17
Cyclopentolate Hcl
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Glaucoma Specialist (Ophthalmology) Physician Overview

How MOLLY WALSH, M.D. fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.

354
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider

MOLLY WALSH, M.D.'s 759 claims are below the specialty average of 2,962.

Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in North Carolina

Other clinicians with the same primary specialty enrolled in North Carolina, drawn from the same CMS NPPES roster as WALSH.

Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MOLLY WALSH, M.D.'s specialty?
MOLLY WALSH, M.D. specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in SOUTHERN PINES, North Carolina. Credentials: M.D..
How much does MOLLY WALSH, M.D. prescribe under Medicare Part D?
In 2023, MOLLY WALSH, M.D. wrote 759 Medicare Part D claims totaling $33K in drug costs for 251 beneficiaries.
What is MOLLY WALSH, M.D.'s Medicare quality score?
MOLLY WALSH, M.D. has a CMS MIPS Final Score of 89.8555/100 (Quality: 100, Cost: 66.185). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MOLLY WALSH, M.D. located?
MOLLY WALSH, M.D. is located at 2170 MIDLAND RD, SOUTHERN PINES, NC, 28387. Phone: (910) 295-2100.
What is MOLLY WALSH, M.D.'s NPI number?
MOLLY WALSH, M.D.'s National Provider Identifier (NPI) is 1891875985, issued on 10/16/2006.
Does MOLLY WALSH, M.D. prescribe more brand-name or generic drugs?
MOLLY WALSH, M.D.'s prescribing is 31% brand-name and 69% generic drugs by claim count, with $20K in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US?
There are 354 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does MOLLY WALSH, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MOLLY WALSH, M.D.'s most frequently prescribed drugs include Prednisolone Acetate, Ofloxacin, Ketorolac Tromethamine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MOLLY WALSH, M.D. accept Medicare?
MOLLY WALSH, M.D. appears in CMS Medicare data with 759 Part D claims and 251 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MOLLY WALSH, M.D.'s credentials?
MOLLY WALSH, M.D.'s NPI is 1891875985 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology